Hill's Pet Nutrition vs Nike
Side-by-side comparison of AI visibility scores, market position, and capabilities
Colgate-Palmolive subsidiary (NYSE: CL); $4.48B revenue 2024 (+4.4% YoY); #1 vet-recommended therapeutic pet food; Science Diet and Prescription Diet lines sold in 100+ countries
About
Hill's Pet Nutrition is a premium pet food company founded in 1948 by veterinarian Mark Morris Sr., who developed a therapeutic kidney diet for a guide dog — an origin story that established the company's foundational identity as a veterinarian-recommended, science-based nutrition brand. Acquired by Colgate-Palmolive in 1976, Hill's has operated as a wholly owned subsidiary ever since, with its R&D, manufacturing, and go-to-market strategy aligned tightly with the veterinary community as both a clinical partner and primary distribution channel.\n\nHill's product portfolio is organized around two flagship lines: Science Diet, a life-stage and lifestyle nutrition range for healthy pets sold through veterinarians and pet specialty retailers; and Prescription Diet, a therapeutic nutrition line for pets with specific health conditions including kidney disease, urinary issues, obesity, diabetes, and food sensitivities that requires veterinary recommendation. The Prescription Diet line is Hill's most defensible product — its clinical validation, veterinary relationships, and regulatory positioning create high barriers to entry that commodity pet food brands cannot easily overcome.\n\nHill's Pet Nutrition is the veterinarian-recommended #1 pet food brand in the US and a major revenue contributor to Colgate-Palmolive's consumer products portfolio. As pet humanization drives premiumization in the $140B+ global pet care market, Hill's Prescription Diet line benefits from both the growing willingness to spend on pet health and the shift toward preventive and therapeutic nutrition supported by veterinary guidance. The brand's clinical heritage, vet channel dominance, and Colgate-Palmolive's global distribution infrastructure give it a durable competitive position in premium and prescription pet nutrition.
Beaverton global athletic footwear and apparel (NYSE: NKE) at $51.4B FY2024 revenue with 18% market share;
About
Nike, Inc. is a Beaverton, Oregon-based global athletic footwear, apparel, and equipment company — publicly traded on the New York Stock Exchange (NYSE: NKE) as a Dow Jones Industrial Average and S&P 500 component — generating $51.4 billion in fiscal year 2024 (ended May 31, 2024) revenue with approximately 83,700 employees worldwide and approximately 18% global athletic footwear market share. Nike brands include Nike (performance footwear, apparel, and equipment), Jordan Brand (lifestyle basketball and athletic), and Converse (lifestyle footwear). In September 2024, Elliott Hill returned to Nike as President and CEO (replacing John Donahoe who had led the company since 2020), launching a "Win Now" strategy focused on sport performance product investment, wholesale partner relationship restoration, and competitive positioning in running and basketball categories. Nike Direct (direct-to-consumer e-commerce and owned stores) generated 44% of FY2024 revenue. Nike was founded in 1964 as Blue Ribbon Sports by Phil Knight and Bill Bowerman; renamed Nike in 1978 with IPO in 1980.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Hill's Pet Nutrition vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.